Severe reversible reticulocytopenic anemia associated with quinupristin/dalfopristin RP59500 therapy

Clin Infect Dis. 1997 Jul;25(1):156. doi: 10.1086/516890.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Anemia, Hemolytic / blood
  • Anemia, Hemolytic / chemically induced*
  • Anemia, Hemolytic / complications
  • Anti-Bacterial Agents / adverse effects*
  • Anti-Bacterial Agents / therapeutic use
  • Female
  • Humans
  • Middle Aged
  • Osteomyelitis / blood
  • Osteomyelitis / complications
  • Osteomyelitis / drug therapy
  • Reticulocytes*
  • Staphylococcal Infections / blood
  • Staphylococcal Infections / complications
  • Staphylococcal Infections / drug therapy
  • Virginiamycin / adverse effects*
  • Virginiamycin / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Virginiamycin
  • quinupristin-dalfopristin